Publications by authors named "Eric Utt"

Claim this Profile
C
Ceftazidime-avibactam for the treatment of Pseudomonas aeruginosa: a plain language summary.
Pattarachai Kiratisin, Marie Kempf, Gregory Stone, Eric Utt

Future Microbiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
activity of ceftazidime-avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020.
Gregory Stone, Mark Wise, Eric Utt

Microbiol Spectr· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for Estabrook et al., "Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Collected as Part of a Global Surveillance Study, 2018 to 2019".
Mark Estabrook, Astrid Muyldermans, Daniel Sahm, Denis Pierard, Gregory Stone, Eric Utt

Antimicrob Agents Chemother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro Activity of Ceftaroline Against Isolates of Gram-Positive Bacteria from Patients with Bloodstream Infections Collected as a Part of ATLAS Between 2017 and 2020.
Marie Kempf, Francis F Arhin, Alona Kuraieva, Eric Utt

Infect Drug Resist· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017-2020.
Pattarachai Kiratisin, Marie Kempf, Gregory Stone, Eric Utt

J Glob Antimicrob Resist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019.
Ana C Gales, Gregory Stone, Daniel F Sahm, Mark G Wise, Eric Utt

J Antimicrob Chemother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019-2020.
Alona Kuraieva, Guillermo Cabezas-Camarero, Pattarachai Kiratisin, Eric Utt

Antibiotics (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017-2019.
Eric Utt, Michal Kantecki, Guillermo Cabezas-Camarero, Susanna Esposito

J Glob Antimicrob Resist· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Collected as Part of a Global Surveillance Study, 2018 to 2019.
Mark Estabrook, Astrid Muyldermans, Daniel Sahm, Denis Pierard, Gregory Stone, Eric Utt

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of an antifungal medicine isavuconazole used in treatment of mold infections in China: A plain language summary.
Ran Jing, Ian Morrissey, Meng Xiao, Tian-Shu Sun, Ge Zhang, Eric A Utt

Future Microbiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).
Harald Seifert, Joseph Blondeau, Kai Lucaßen, Eric A Utt

J Glob Antimicrob Resist· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019.
Marie Kempf, Francis F Arhin, Gregory Stone, Eric Utt

J Glob Antimicrob Resist· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Activity of Ceftazidime-Avibactam and Comparators Against Fluoroquinolone-Resistant Collected Globally from Antimicrobial Testing Leadership and Surveillance: 2018-2019.
Pattarachai Kiratisin, Francis F Arhin, Gregory Stone, Eric Utt

Microb Drug Resist· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China.
Ran Jing, Ian Morrissey, Meng Xiao, Tian-Shu Sun, Ge Zhang, Eric A Utt

Infect Drug Resist· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal drugs work together to treat germs causing fungal infections.
Michael A Pfaller, Shawn A Messer, Lalitagauri M Deshpande, Paul R Rhomberg, Eric A Utt

Future Microbiol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.
Michael A Pfaller, Shawn A Messer, Lalitagauri M Deshpande, Paul R Rhomberg, Eric A Utt

Antimicrob Agents Chemother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States.
John M McLaughlin, Eric A Utt, Nina M Hill, Verna L Welch, Edward Power

Hum Vaccin Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines: A review of immune-based interventions to prevent and treat disease.
Demissie Alemayehu, Eric Utt, Charles Knirsch

J Clin Pharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis